UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Doctor fuels controversy with YouTube advice on how to take dog dewormer
by Lee Hye-seon
2019-11-18 16:47
KDA, KBR team up for global promotion of Korean medicine
by Lee Hye-seon
2019-11-08 14:09
Regulator allows easier access to clinical trial participation, inquiry
by Lee Hye-seon
2019-10-24 15:36
Drug regulator to hire 87 more reviewers next year
by Lee Hye-seon
2019-10-11 16:35
Allergan Korea to replace breast implant without time limit
by Lee Hye-seon
2019-10-08 15:22
라인
Civic group protests regulator’s inaction over insulin pumps FDA recalled
by Lee Hye-seon
2019-10-07 16:10
‘New law to support advanced biopharmaceuticals, ensure safety’
by Lee Hye-seon
2019-10-04 15:18
Authorities to test drugs of ranitidine family for carcinogen risk
by Lee Hye-seon
2019-10-02 14:51
Allergan to compensate breast implant recipients for damage
by Lee Hye-seon
2019-09-30 15:33
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
by Lee Hye-seon
2019-09-30 11:25
라인
Ranitidine heartburn drugs banned due to carcinogen risk
by Lee Hye-seon
2019-09-26 13:32
Ministry to announce results of ranitidine testing for carcinogen
by Lee Hye-seon
2019-09-25 14:46
Indian biosimilar of rituximab to undergo test in Korea
by Lee Hye-seon
2019-09-19 10:31
Regulator inspects heartburn drugs after US finds carcinogen
by Lee Hye-seon
2019-09-16 14:01
Lilly’s migraine treatment Emgality lands in Korea
by Lee Hye-seon
2019-09-05 16:24
라인
Multiple myeloma treatment isatuximab named orphan drug
by Lee Hye-seon
2019-09-03 11:21
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
by Lee Hye-seon
2019-08-22 15:37
‘Ministry to provide quick measures for users of Allergan’s breast implants’
by Lee Hye-seon
2019-08-21 15:20
Combo drugs: latest trend in local pharmaceuticals
by Lee Hye-seon
2019-08-19 16:02
Rare cancer reported in Korea regarding Allergan’s breast implant
by Lee Hye-seon
2019-08-16 14:54
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top